Researchers at the University of Birmingham, UK, are collaborating with scientists from China’s Guangzhou Institutes of Biomedicine and Health (GIBH) to develop new medicines for treating global epidemics. The university’s team has discovered multiple […]
The US Food and Drug Administration (FDA) has approved Dova Pharmaceuticals’ Doptelet drug for patients with thrombocytopenia, a reduction in the number of platelets in the blood, who are scheduled to undergo a medical or […]
Two pharmaceutical companies, BioMarin and Spark, have announced positive results of their separate phase 1/2 studies of treatments for haemophilia A and haemophilia B, suggesting gene therapies may be able to transform how the disorder […]
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) are separately investigating the preliminary results from a study of babies born to Botswanan women infected with the human immunodeficiency virus (HIV), […]
AstraZeneca and MedImmune, its global biologics research and development arm, have announced that respiratory drug Fasenra failed to meet primary endpoints in a Phase III trial. The key drug in AstraZeneca’s pipeline did not demonstrate […]